SCHEMBL5318892

SCHEMBL5318892

OCCc1nn(Cc2ccc(Cl)cc2Cl)c2cc(C(F)(F)F)ccc12

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 4/20 0.43
CYP3A4 P08684 3/20 0.43
NPSR1 Q6W5P4 2/20 0.43
CYP2D6 P10635 2/20 0.43
CYP1A2 P05177 1/20 0.43
TSHR P16473 1/20 0.43
PMP22 Q01453 1/20 0.43
HIF1A Q16665 1/20 0.43
AKR1B1 P15121 1/20 0.40
NPC1 O15118 1/20 0.39
SLC9A1 P19634 1/20 0.38
LMNA P02545 1/20 0.38
SLC22A12 Q96S37 1/20 0.37
PPARG P37231 2/20 0.37
NR1H2 P55055 1/20 0.36
NR1H3 Q13133 1/20 0.36
CCR2 P41597 1/20 0.36
CYP2C19 P33261 2/20 0.36
ENPP2 Q13822 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5316051 0.94 NPSR1 (0.42) CYP2C9CYP3A4NPSR1CYP2D6CYP1A2
SCHEMBL5322190 0.93 NPSR1 (0.41) CYP2C9CYP3A4NPSR1CYP2D6CYP1A2
SCHEMBL5317364 0.92 NPSR1 (0.41) CYP2C9CYP3A4NPSR1CYP2D6CYP1A2
SCHEMBL12693792 0.91 NPSR1 (0.45) CYP2C9CYP3A4NPSR1CYP2D6CYP1A2
SCHEMBL5267313 0.90 NR1H2 (0.44) CYP2C9CYP3A4CYP2D6CYP1A2AKR1B1
SCHEMBL5319045 0.90 NR1H2 (0.43) LMNASLC22A12PPARGNR1H2NR1H3
SCHEMBL5270492 0.89 AKR1B1 (0.39) CYP2C9CYP3A4CYP2D6CYP1A2AKR1B1
SCHEMBL1050445 0.88 PPARG (0.49) CYP2C9CYP3A4NPSR1CYP2D6CYP1A2
SCHEMBL5317751 0.87 CYP1A2 (0.47) CYP2C9CYP3A4NPSR1CYP2D6CYP1A2
SCHEMBL5317956 0.85 AKR1B1 (0.56) CYP2C9CYP3A4NPSR1CYP2D6CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786424-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT The University of Kansas (US) 2007-05-23 EP claimed
WO-2006023704-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT UNIVERSITY OF KANSAS (US) 2006-03-02 WO claimed